Although medical and surgical treatments available today for the ischemic heart disease patients diminish the risk of
acute myocardial infarction and reduce to some extent the incidence of recurrent heart attack, one of the unsolved challenges is to affect myocardium remodeling
occurring during ischemic heart failure.